Depo-Medrol Lidocaine 40 mg/mL
Depo-Medrol Lidocaine 40 mg/mL is a medicine authorised by Swissmedic under authorisation number 38546. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 February 1975 and the authorisation is valid without a time limit. ATC code H02BX01 places the medicine in the group Corticosteroids for systemic use.
| Authorisation number | 38546 |
|---|---|
| Name | Depo-Medrol Lidocaine 40 mg/mL |
| Full name | Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H02BX01 |
| First authorisation | 03 February 1975 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Depo-Medrol Lidocaine 40 mg/mL, Injektionssuspension | B | 03 February 1975 |
| 2 | Depo-Medrol Lidocaine 80 mg/2 mL, Injektionssuspension | B | 14 July 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 1 x 1 mL | Durchstechflasche(n) | H02BX01 | 07.07.23 | B |
| 31 | 25 x 1 mL | Durchstechflasche(n) | H02BX01 | 07.07.23 | B |
| 23 | 1 x 2 mL | Durchstechflasche(n) | H02BX01 | 07.07.23 | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Depo-Medrol Lidocaine 40 mg/mL authorised in Switzerland?
Yes. Depo-Medrol Lidocaine 40 mg/mL is authorised by Swissmedic under authorisation number 38546, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Depo-Medrol Lidocaine 40 mg/mL have?
Depo-Medrol Lidocaine 40 mg/mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Depo-Medrol Lidocaine 40 mg/mL?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.